Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
Novartis
Novartis
Sotio Biotech Inc.
Pfizer
MacroGenics
Ocellaris Pharma, Inc.
Fusion Pharmaceuticals Inc.
Alpha Tau Medical LTD.
Regeneron Pharmaceuticals
HiFiBiO Therapeutics
Pfizer
MacroGenics
NuCana plc
Eli Lilly and Company
Kymab Limited
Seagen Inc.
Turnstone Biologics, Corp.
Seagen Inc.
Astellas Pharma Inc
Molecular Templates, Inc.
Inhibrx Biosciences, Inc
Pfizer
Eisai Inc.
Atreca, Inc.
Fate Therapeutics
Oncorus, Inc.
Seagen Inc.
Nektar Therapeutics
Rubius Therapeutics
Repertoire Immune Medicines
Amgen
Genocea Biosciences, Inc.
Incyte Corporation
MacroGenics
Dynavax Technologies Corporation
Incyte Corporation
Seagen Inc.
Incyte Corporation
Daiichi Sankyo
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
Icahn School of Medicine at Mount Sinai
Case Comprehensive Cancer Center